cp094 has been researched along with beta-Thalassemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abeysinghe, RD; Epemolu, O; Hider, RC; Hoyes, KP; Porter, JB; Singh, S | 1 |
Abeysinghe, RD; Bagshaw, AP; Farquharson, MJ; Porter, JB | 1 |
1 review(s) available for cp094 and beta-Thalassemia
Article | Year |
---|---|
Lessons from preclinical and clinical studies with 1,2-diethyl-3-hydroxypyridin-4-one, CP94 and related compounds.
Topics: Animals; beta-Thalassemia; Cell Line; Deferoxamine; Guinea Pigs; Humans; Iron; Iron Chelating Agents; Mice; Pyridones; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
1 other study(ies) available for cp094 and beta-Thalassemia
Article | Year |
---|---|
The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload.
Topics: Animals; beta-Thalassemia; Biophysical Phenomena; Biophysics; Female; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Pyridones; Rats; Rats, Sprague-Dawley; Skin; Spectrometry, X-Ray Emission; Tissue Distribution | 2000 |